CAS: 2411440-41-8
(S)-2-(5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carboxamido)-5-guanidinopentanoic acid
CAS:2411440-41-8
Formula:
C25H26Cl2N4O3S
Purity:
95%
Color and Shape:
Solid
Molecular weight:
533.46994
Ref: IN-DA0201XE
| 5mg | 139.00 € | ||
| 10mg | 202.00 € | ||
| 25mg | 289.00 € | ||
| 50mg | 614.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Monday 5 May 2025
Ref: 54-BUP03473
| 25mg | 755.00 € | ||
| 50mg | 1,071.00 € | ||
| 100mg | 1,390.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
(S)-2-(5-(Bis(4-Chlorophenyl)Methyl)-3-Methylthiophene-2-Carboxamido)-5-Guanidinopentanoic Acid
CAS:2411440-41-8
Purity:
98%
Molecular weight:
533.47g/mol
Ref: 54-OR1023322
| 100mg | 787.00 € | ||
| 250mg | 1,216.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
JR14a
CAS:2411440-41-8
JR14a (5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carbonyl)-l-arginine hydrochloride) is a potent antagonist of human complement C3a receptor.
Formula:
C25H26Cl2N4O3S
Purity:
99.76%
Color and Shape:
Solid
Molecular weight:
533.47
Ref: TM-T9316
| 1mg | 92.00 € | ||
| 5mg | 188.00 € | ||
| 10mg | 298.00 € | ||
| 25mg | 507.00 € | ||
| 50mg | 730.00 € | ||
| 100mg | 1,026.00 € | ||
| 1mL*10mM (DMSO) | 215.00 € |
Estimated delivery in United States, on Monday 12 May 2025
JR14a
CAS:2411440-41-8
Please enquire for more information about JR14a including the price, delivery time and more detailed …
Formula:
C25H26Cl2N4O3S
Purity:
Min. 95%
Molecular weight:
533.5 g/mol
Ref: 3D-LWD44041
| 25mg | 1,040.00 € | ||
| 50mg | 1,364.00 € | ||
| 100mg | 2,126.00 € |
Estimated delivery in United States, on Monday 16 Jun 2025
